APT Medical Inc Total Liabilities

Latest as of March 2026: CN¥423.40 Million CNY ≈ $61.96 Million USD

APT Medical Inc total liabilities. Based on the latest financial reports, APT Medical Inc (688617) has total liabilities worth CN¥423.40 Million CNY (≈ $61.96 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 688617 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of APT Medical Inc (2017–2025)

Total liabilities of APT Medical Inc from 2017 to 2025. This chart illustrates how APT Medical Inc's total liabilities have evolved over time, based on quarterly financial data.

APT Medical Inc Competitors by Total Liabilities

The table below lists competitors of APT Medical Inc ranked by their total liabilities.

Company Country Total Liabilities
Giant Network Group Co Ltd
SHE:002558
China CN¥3.48 Billion
Kuang Chi Technologies Co Ltd
SHE:002625
China CN¥1.83 Billion
Hebei Yangyuan ZhiHui Beverage Co Ltd
SHG:603156
China CN¥2.33 Billion
Carlsberg A/S
CO:CARL-A
Denmark Dkr123.28 Billion
SHISEIDO CO. ADR
F:SHDA
Germany €645.99 Billion
Shan Dong Sun Paper Industry Joint Stock Co Ltd
SHE:002078
China CN¥28.55 Billion
Perseus Mining Ltd
AU:PRU
Australia AU$465.51 Million

Liability Composition Analysis (2017–2025)

This chart breaks down APT Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 688617 asset base.

Liquidity & Leverage Metrics

APT Medical Inc Total Liabilities Ratios Explained

APT Medical Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 5.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.14 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.12 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how APT Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for APT Medical Inc (2017–2025)

The table below shows the annual total liabilities of APT Medical Inc from 2017 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥477.40 Million
≈ $69.86 Million
+12.10%
2024-12-31 CN¥425.85 Million
≈ $62.32 Million
-30.30%
2023-12-31 CN¥610.98 Million
≈ $89.41 Million
+40.48%
2022-12-31 CN¥434.91 Million
≈ $63.64 Million
+95.89%
2021-12-31 CN¥222.02 Million
≈ $32.49 Million
+60.16%
2020-12-31 CN¥138.62 Million
≈ $20.29 Million
-35.56%
2019-12-31 CN¥215.13 Million
≈ $31.48 Million
+290.28%
2018-12-31 CN¥55.12 Million
≈ $8.07 Million
+43.89%
2017-12-31 CN¥38.31 Million
≈ $5.61 Million
--

About APT Medical Inc

SHG:688617 China Medical Devices
Market Cap
$5.91 Billion
CN¥40.37 Billion CNY
Market Cap Rank
#3100 Global
#366 in China
Share Price
CN¥285.26
Change (1 day)
+1.16%
52-Week Range
CN¥181.27 - CN¥285.26
All Time High
CN¥453.00
About

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more